These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21920320)

  • 1. Application of computational methods to the design of fatty acid amide hydrolase (FAAH) inhibitors based on a carbamic template structure.
    Lodola A; Rivara S; Mor M
    Adv Protein Chem Struct Biol; 2011; 85():1-26. PubMed ID: 21920320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors.
    Tarzia G; Duranti A; Tontini A; Piersanti G; Mor M; Rivara S; Plazzi PV; Park C; Kathuria S; Piomelli D
    J Med Chem; 2003 Jun; 46(12):2352-60. PubMed ID: 12773040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes.
    Alexander JP; Cravatt BF
    Chem Biol; 2005 Nov; 12(11):1179-87. PubMed ID: 16298297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the role of carbamate reactivity in fatty acid amide hydrolase inhibition by QM/MM mechanistic modelling.
    Lodola A; Capoferri L; Rivara S; Chudyk E; Sirirak J; Dyguda-Kazimierowicz E; Andrzej Sokalski W; Mileni M; Tarzia G; Piomelli D; Mor M; Mulholland AJ
    Chem Commun (Camb); 2011 Mar; 47(9):2517-9. PubMed ID: 21240393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
    Vincent F; Nguyen MT; Emerling DE; Kelly MG; Duncton MA
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6793-6. PubMed ID: 19850474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
    Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Heterocycle-phenyl N-alkylcarbamates as FAAH inhibitors: design, synthesis and 3D-QSAR studies.
    Käsnänen H; Myllymäki MJ; Minkkilä A; Kataja AO; Saario SM; Nevalainen T; Koskinen AM; Poso A
    ChemMedChem; 2010 Feb; 5(2):213-31. PubMed ID: 20024981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational insights into function and inhibition of fatty acid amide hydrolase.
    Palermo G; Rothlisberger U; Cavalli A; De Vivo M
    Eur J Med Chem; 2015 Feb; 91():15-26. PubMed ID: 25240419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.
    Mor M; Rivara S; Lodola A; Plazzi PV; Tarzia G; Duranti A; Tontini A; Piersanti G; Kathuria S; Piomelli D
    J Med Chem; 2004 Oct; 47(21):4998-5008. PubMed ID: 15456244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tandem mass spectrometric data-FAAH inhibitory activity relationships of some carbamic acid O-aryl esters.
    Basso E; Duranti A; Mor M; Piomelli D; Tontini A; Tarzia G; Traldi P
    J Mass Spectrom; 2004 Dec; 39(12):1450-5. PubMed ID: 15578755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of on-target FAAH inhibitors.
    Deutsch DG
    Chem Biol; 2005 Nov; 12(11):1157-8. PubMed ID: 16298293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights in the mechanism of action and inhibition of N-acylethanolamine acid amidase by means of computational methods.
    Lodola A; Rivara S; Mor M
    Adv Protein Chem Struct Biol; 2014; 96():219-34. PubMed ID: 25443959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.
    Gattinoni S; Simone CD; Dallavalle S; Fezza F; Nannei R; Battista N; Minetti P; Quattrociocchi G; Caprioli A; Borsini F; Cabri W; Penco S; Merlini L; Maccarrone M
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4406-11. PubMed ID: 20591666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonempirical energetic analysis of reactivity and covalent inhibition of fatty acid amide hydrolase.
    Chudyk EI; Dyguda-Kazimierowicz E; Langner KM; Sokalski WA; Lodola A; Mor M; Sirirak J; Mulholland AJ
    J Phys Chem B; 2013 Jun; 117(22):6656-66. PubMed ID: 23654226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantum mechanics/molecular mechanics modeling of fatty acid amide hydrolase reactivation distinguishes substrate from irreversible covalent inhibitors.
    Lodola A; Capoferri L; Rivara S; Tarzia G; Piomelli D; Mulholland A; Mor M
    J Med Chem; 2013 Mar; 56(6):2500-12. PubMed ID: 23425199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the mechanism and inhibition of fatty acid amide hydrolase from quantum mechanics/molecular mechanics (QM/MM) modelling.
    Lodola A; Mor M; Sirirak J; Mulholland AJ
    Biochem Soc Trans; 2009 Apr; 37(Pt 2):363-7. PubMed ID: 19290863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of FAAH inhibitors: cyclohexylcarbamic acid biphenyl esters with chemical modulation at the proximal phenyl ring.
    Tarzia G; Duranti A; Gatti G; Piersanti G; Tontini A; Rivara S; Lodola A; Plazzi PV; Mor M; Kathuria S; Piomelli D
    ChemMedChem; 2006 Jan; 1(1):130-9. PubMed ID: 16892344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-(triazolyl)methyl carbamates as a novel and potent class of fatty acid amide hydrolase (FAAH) inhibitors.
    Colombano G; Albani C; Ottonello G; Ribeiro A; Scarpelli R; Tarozzo G; Daglian J; Jung KM; Piomelli D; Bandiera T
    ChemMedChem; 2015 Feb; 10(2):380-95. PubMed ID: 25338703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ω-Imidazolyl- and ω-Tetrazolylalkylcarbamates as Inhibitors of Fatty Acid Amide Hydrolase: Biological Activity and in vitro Metabolic Stability.
    Terwege T; Hanekamp W; Garzinsky D; König S; Koch O; Lehr M
    ChemMedChem; 2016 Feb; 11(4):429-43. PubMed ID: 26732805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).
    Lodola A; Castelli R; Mor M; Rivara S
    Expert Opin Ther Pat; 2015; 25(11):1247-66. PubMed ID: 26413912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.